Reported 4,190 shares, unchanged from the prior quarter.
Reported value 21.6%; share count 0.0% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-09-30 | 2355911 |
| 2025-12-31 | 3234135 |
| 2026-03-31 | 3237362 |
| 2026-06-30 | 2612633 |
| 2026-09-30 | 3177151 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 4,190 | 0 (0.0%) | 2.07% | $3,177,151 | 2026-11-16 | |
| Q2 2026 | Unchanged | 4,190 | 0 (0.0%) | 1.47% | $2,612,633 | 2026-08-14 | |
| Q1 2026 | Unchanged | 4,190 | 0 (0.0%) | 2.05% | $3,237,362 | 2026-05-15 | |
| Q4 2025 | Unchanged | 4,190 | 0 (0.0%) | 1.45% | $3,234,135 | 2026-02-17 | |
| Q3 2025 | New | 4,190 | +4,190 (0.0%) | 1.31% | $2,355,911 | 2025-11-14 |
Who else reported the position
1517 managers reported REGENERON PHARMACEUTICALS for Q3 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BlackRock Inc | Reduced | 8,849,583 | -263,923 | 0.1% | $6,710,372,953 | 9 qtrs |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 6,522,346 | -107,413 | 0.1% | $4,945,699,301 | 3 qtrs |
| STATE STREET CORPORATION | Added | 4,881,362 | +46,674 | 0.11% | $3,701,390,364 | 54 qtrs |
| Dodge & Cox | Reduced | 4,774,489 | -96,648 | 1.94% | $3,620,351,774 | 20 qtrs |
| Invesco Ltd | Reduced | 3,721,270 | -219,395 | 0.22% | $2,821,727,063 | 54 qtrs |
| FRANKLIN RESOURCES INC | Added | 2,950,805 | +178,966 | 0.58% | $2,746,225,687 | 54 qtrs |
| JPMorgan Chase & Co | Reduced | 3,307,392 | -466,807 | 0.13% | $2,482,231,986 | 54 qtrs |
| VANGUARD PORTFOLIO MANAGEMENT LLC | Reduced | 3,111,677 | -63,636 | 0.11% | $2,359,491,319 | 3 qtrs |
| GEODE CAPITAL MANAGEMENT LLC | Added | 2,632,826 | +7,016 | 0.1% | $1,992,068,413 | 54 qtrs |
| Nuveen LLC | Reduced | 1,955,949 | -64,025 | 0.35% | $1,483,137,489 | 7 qtrs |
Filing details and methodology As reported
- Report period
- September 30, 2026
- Filed
- November 16, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 4,190
- Shared
- 0
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.